British pharmaceuticals giant GlaxoSmith-Kline is to cut up to 4,000 more jobs as it restructures its workforce and focuses increasingly on emerging markets, The Sunday Times reported. The majority of the jobs will be lost in the United States and Europe, the newspaper said.
GSK, which employs just under 100,000 staff globally, is expected to reveal plans for the job cuts when it releases its annual results on Thursday, the report said.
Its Anglo-Swedish rival AstraZeneca announced on Thursday it plans to axe 8,000 more jobs world-wide by 2014, extending a cost-cutting drive despite soaring profits. This led to it recently cutting 2,000 sales jobs in the United States while adding 1,500 staff in China.
Comments
Comments are closed.